Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | S-1 | tm2115750-9_s1.htm | S-1 | 4267033 |
2 | EXHIBIT 3.1 | tm2115750d10_ex3-1.htm | EX-3.1 | 153264 |
3 | EXHIBIT 3.2 | tm2115750d10_ex3-2.htm | EX-3.2 | 111402 |
4 | EXHIBIT 3.3 | tm2115750d10_ex3-3.htm | EX-3.3 | 61052 |
5 | EXHIBIT 3.4 | tm2115750d10_ex3-4.htm | EX-3.4 | 137137 |
6 | EXHIBIT 4.1 | tm2115750d10_ex4-1.htm | EX-4.1 | 11516 |
7 | EXHIBIT 10.1 | tm2115750d10_ex10-1.htm | EX-10.1 | 194735 |
8 | EXHIBIT 10.2 | tm2115750d10_ex10-2.htm | EX-10.2 | 137665 |
9 | EXHIBIT 10.3 | tm2115750d10_ex10-3.htm | EX-10.3 | 74484 |
10 | EXHIBIT 10.4 | tm2115750d10_ex10-4.htm | EX-10.4 | 122662 |
11 | EXHIBIT 10.9 | tm2115750d10_ex10-9.htm | EX-10.9 | 17436 |
12 | EXHIBIT 10.10 | tm2115750d10_ex10-10.htm | EX-10.10 | 366604 |
13 | EXHIBIT 10.11 | tm2115750d10_ex10-11.htm | EX-10.11 | 262117 |
14 | EXHIBIT 10.12 | tm2115750d10_ex10-12.htm | EX-10.12 | 209994 |
15 | EXHIBIT 10.13 | tm2115750d10_ex10-13.htm | EX-10.13 | 205098 |
16 | EXHIBIT 10.14 | tm2115750d10_ex10-14.htm | EX-10.14 | 498917 |
17 | EXHIBIT 10.15 | tm2115750d10_ex10-15.htm | EX-10.15 | 78371 |
18 | EXHIBIT 10.16 | tm2115750d10_ex10-16.htm | EX-10.16 | 55667 |
19 | EXHIBIT 10.17 | tm2115750d10_ex10-17.htm | EX-10.17 | 82239 |
20 | EXHIBIT 10.18 | tm2115750d10_ex10-18.htm | EX-10.18 | 101220 |
21 | EXHIBIT 10.19 | tm2115750d10_ex10-19.htm | EX-10.19 | 54047 |
22 | EXHIBIT 10.20 | tm2115750d10_ex10-20.htm | EX-10.20 | 97229 |
23 | EXHIBIT 21.1 | tm2115750d10_ex21-1.htm | EX-21.1 | 2197 |
24 | EXHIBIT 23.1 | tm2115750d10_ex23-1.htm | EX-23.1 | 2039 |
25 | GRAPHIC | lg_xilio-4c.jpg | GRAPHIC | 87057 |
26 | GRAPHIC | tm2115750d1-lc_highdosebw.jpg | GRAPHIC | 59535 |
27 | GRAPHIC | tm2115750d1-lc_pembro4c.jpg | GRAPHIC | 118788 |
28 | GRAPHIC | tm2115750d1-lc_potent4c.jpg | GRAPHIC | 129482 |
29 | GRAPHIC | tm2115750d1-lc_proteoly4c.jpg | GRAPHIC | 84879 |
30 | GRAPHIC | tm2115750d1-lc_singledose4c.jpg | GRAPHIC | 82408 |
31 | GRAPHIC | tm2115750d1-ph_receptor4c.jpg | GRAPHIC | 105641 |
32 | GRAPHIC | tm2115750d10_ex4-1img001.jpg | GRAPHIC | 579886 |
33 | GRAPHIC | tm2115750d10_ex4-1img002.jpg | GRAPHIC | 358272 |
34 | GRAPHIC | tm2115750d5-bc_masked4c.jpg | GRAPHIC | 69017 |
35 | GRAPHIC | tm2115750d5-fc_101trial4c.jpg | GRAPHIC | 56084 |
36 | GRAPHIC | tm2115750d5-fc_202trial4c.jpg | GRAPHIC | 70746 |
37 | GRAPHIC | tm2115750d5-fc_antibody4c.jpg | GRAPHIC | 203189 |
38 | GRAPHIC | tm2115750d5-fc_cytokine4c.jpg | GRAPHIC | 206005 |
39 | GRAPHIC | tm2115750d5-lc_affect4clr.jpg | GRAPHIC | 91391 |
40 | GRAPHIC | tm2115750d5-lc_decouples4c.jpg | GRAPHIC | 104873 |
41 | GRAPHIC | tm2115750d5-lc_demonstrat4c.jpg | GRAPHIC | 104998 |
42 | GRAPHIC | tm2115750d5-lc_tolerated4c.jpg | GRAPHIC | 50003 |
43 | GRAPHIC | tm2115750d5-lc_xtx2024clr.jpg | GRAPHIC | 39924 |
44 | GRAPHIC | tm2115750d5-ph_platform4c.jpg | GRAPHIC | 136815 |
45 | GRAPHIC | tm2115750d9-bc_pstat4c.jpg | GRAPHIC | 115933 |
46 | GRAPHIC | tm2115750d9-bc_sign4c.jpg | GRAPHIC | 131946 |
47 | GRAPHIC | tm2115750d9-lc_peri24clr.jpg | GRAPHIC | 89193 |
48 | GRAPHIC | tm2115750d9-lc_posttr4c.jpg | GRAPHIC | 98009 |
49 | GRAPHIC | tm2115750d9-lc_splenom4c.jpg | GRAPHIC | 77812 |
50 | GRAPHIC | tm2115750d9-lc_toxic4clr.jpg | GRAPHIC | 117874 |
51 | GRAPHIC | tm2115750d9-lc_toxicity4c.jpg | GRAPHIC | 119382 |
52 | GRAPHIC | tm2115750d9-lc_well4c.jpg | GRAPHIC | 159195 |
53 | GRAPHIC | tm2115750d9-tbl_pipe4c.jpg | GRAPHIC | 103516 |
Complete submission text file | 0001104659-21-122045.txt | 12438758 |
IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-259973 | Film No.: 211299592
SIC: 2834 Pharmaceutical Preparations